Dr. Harlan Levine, AccessHope’s Chair of the Board, recently appeared on Willis Towers Watson’s Cure for the Common Co. podcast series, where he spoke with its host, Steve Blumenfield, and the North America Health and Benefits Strategic Growth Leader for Willis Towers Watson, Ron Fontanetta, about AccessHope’s dedication to democratizing cancer expertise while closing the cancer knowledge gap. In the episode, he shares how AccessHope’s unique model supports employers’ efforts to promote early cancer intervention for high-risk employees. He also highlights the benefits of AccessHope’s cancer support services, including Expert Advisory Review, Accountable Precision Oncology, and Clinical Support Team, explaining how our people-oriented approach is addressing cancer health disparities around the nation.
